1
|
Bláha BAF, Morris SA, Ogonah OW, Maucourant S, Crescente V, Rosenberg W, Mukhopadhyay TK. Development of a high-throughput microscale cell disruption platform for Pichia pastoris in rapid bioprocess design. Biotechnol Prog 2017; 34:130-140. [PMID: 28884522 DOI: 10.1002/btpr.2555] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2017] [Revised: 07/28/2017] [Indexed: 11/10/2022]
Abstract
The time and cost benefits of miniaturized fermentation platforms can only be gained by employing complementary techniques facilitating high-throughput at small sample volumes. Microbial cell disruption is a major bottleneck in experimental throughput and is often restricted to large processing volumes. Moreover, for rigid yeast species, such as Pichia pastoris, no effective high-throughput disruption methods exist. The development of an automated, miniaturized, high-throughput, noncontact, scalable platform based on adaptive focused acoustics (AFA) to disrupt P. pastoris and recover intracellular heterologous protein is described. Augmented modes of AFA were established by investigating vessel designs and a novel enzymatic pretreatment step. Three different modes of AFA were studied and compared to the performance high-pressure homogenization. For each of these modes of cell disruption, response models were developed to account for five different performance criteria. Using multiple responses not only demonstrated that different operating parameters are required for different response optima, with highest product purity requiring suboptimal values for other criteria, but also allowed for AFA-based methods to mimic large-scale homogenization processes. These results demonstrate that AFA-mediated cell disruption can be used for a wide range of applications including buffer development, strain selection, fermentation process development, and whole bioprocess integration. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 34:130-140, 2018.
Collapse
Affiliation(s)
- Benjamin A F Bláha
- The Advanced Centre for Biochemical Engineering, Dept. of Biochemical Engineering, University College London, London, WC1E 7JE, U.K
| | - Stephen A Morris
- The Advanced Centre for Biochemical Engineering, Dept. of Biochemical Engineering, University College London, London, WC1E 7JE, U.K.,iQur Limited, London Bioscience Innovation Centre, London, NW1 0NH, U.K
| | - Olotu W Ogonah
- The Advanced Centre for Biochemical Engineering, Dept. of Biochemical Engineering, University College London, London, WC1E 7JE, U.K
| | - Sophie Maucourant
- iQur Limited, London Bioscience Innovation Centre, London, NW1 0NH, U.K
| | | | - William Rosenberg
- iQur Limited, London Bioscience Innovation Centre, London, NW1 0NH, U.K
| | - Tarit K Mukhopadhyay
- The Advanced Centre for Biochemical Engineering, Dept. of Biochemical Engineering, University College London, London, WC1E 7JE, U.K
| |
Collapse
|
3
|
Noyes A, Huffman B, Berrill A, Merchant N, Godavarti R, Titchener-Hooker N, Coffman J, Sunasara K, Mukhopadhyay T. High throughput screening of particle conditioning operations: II. Evaluation of scale-up heuristics with prokaryotically expressed polysaccharide vaccines. Biotechnol Bioeng 2015; 112:1568-82. [PMID: 25727194 DOI: 10.1002/bit.25580] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2014] [Revised: 02/15/2015] [Accepted: 02/17/2015] [Indexed: 11/08/2022]
Abstract
Multivalent polysaccharide conjugate vaccines are typically comprised of several different polysaccharides produced with distinct and complex production processes. Particle conditioning steps, such as precipitation and flocculation, may be used to aid the recovery and purification of such microbial vaccine products. An ultra scale-down approach to purify vaccine polysaccharides at the micro-scale would greatly enhance productivity, robustness, and speed the development of novel conjugate vaccines. In part one of this series, we described a modular and high throughput approach to develop particle conditioning processes (HTPC) for biologicals that combines flocculation, solids removal, and streamlined analytics. In this second part of the series, we applied HTPC to industrially relevant feedstreams comprised of capsular polysaccharides (CPS) from several bacterial species. The scalability of HTPC was evaluated between 0.8 mL and 13 L scales, with several different scaling methodologies examined. Clarification, polysaccharide yield, impurity clearance, and product quality achieved with HTPC were reproducible and comparable with larger scales. Particle sizing was the response with greatest sensitivity to differences in processing scale and enabled the identification of useful scaling rules. Scaling with constant impeller tip speed or power per volume in the impeller swept zone offered the most accurate scale up, with evidence that time integration of these values provided the optimal basis for scaling. The capability to develop a process at the micro-scale combined with evidence-based scaling metrics provide a significant advance for purification process development of vaccine processes. The USD system offers similar opportunities for HTPC of proteins and other complex biological molecules.
Collapse
Affiliation(s)
- Aaron Noyes
- The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, Bernard Katz Building, Gordon Street, London, WC1E 7JE, UK.,Pfizer Bioprocess R&D, Andover, Massachusetts
| | - Ben Huffman
- Pfizer Bioprocess R&D, Chesterfield, Missouri
| | | | | | | | - Nigel Titchener-Hooker
- The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, Bernard Katz Building, Gordon Street, London, WC1E 7JE, UK
| | | | | | - Tarit Mukhopadhyay
- The Advanced Centre for Biochemical Engineering, Department of Biochemical Engineering, University College London, Bernard Katz Building, Gordon Street, London, WC1E 7JE, UK.
| |
Collapse
|